Akira Okura

Title: Akira Okura: Innovator in Antitumor Research

Introduction

Akira Okura is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antitumor substances. With a total of 6 patents to his name, Okura's work is recognized for its innovative approaches to cancer treatment.

Latest Patents

One of Okura's latest patents is focused on a method for preparing antitumor substance BE-13793C derivatives. This invention relates to 12,13-dihydro-6H-indolo[2,3-a]pyrrolo[3,4-c]carbazole-5,7(6H)-dione derivatives. These derivatives are represented by a specific general formula and include pharmaceutically acceptable salts. The method of preparation and potential uses of these compounds are also detailed in the patent. The invention highlights the versatility of the derivatives, where R¹ denotes a monosaccharide group having 5 to 7 carbon atoms, with hydroxyl groups that can be replaced by various groups.

Career Highlights

Akira Okura is currently associated with Banyu Pharmaceutical Co. Ltd., where he continues to advance his research in pharmaceuticals. His work has been instrumental in developing new therapeutic options for cancer patients.

Collaborations

Okura has collaborated with notable colleagues, including Hiroyuki Suda and Masanori Okanishi, to further enhance the impact of his research.

Conclusion

Akira Okura's innovative contributions to antitumor research exemplify the importance of collaboration and creativity in the pharmaceutical industry. His patents reflect a commitment to improving cancer treatment options, making a significant impact in the field.